Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers

Author: Dr. Neil Love September 13, 2024 Duration: 1:00:59
Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Carolina, review clinical data supporting the application of HER2-targeted therapies for patients with gastrointestinal cancers.

Hosted by Dr. Neil Love, Gastrointestinal Cancer Update is a dedicated audio series for oncology professionals who navigate the complex and rapidly evolving landscape of patient care. Each conversation moves beyond published journal articles to capture the nuanced, real-time thinking of leading clinical researchers from across the globe. The discussions focus squarely on gastrointestinal cancers, delving into the rationale behind emerging strategies, interpreting the latest trial data, and considering how these findings translate into daily practice. This isn't about broad overviews; it's about the specific, often unanswered questions that clinicians face when designing treatment plans. By tuning in, medical oncologists and hematologists gain a direct line to the experts shaping the field, hearing them analyze challenges and debate subtleties that rarely make it into final study reports. The podcast serves as an ongoing, dynamic supplement to traditional education, fostering a deeper understanding that aims to directly inform and refine clinical decision-making at the bedside.
Author: Language: English Episodes: 80

Gastrointestinal Cancer Update
Podcast Episodes